Anand Bhaskar 4
4 · REATA PHARMACEUTICALS INC · Filed Sep 7, 2023
Insider Transaction Report
Form 4
Anand Bhaskar
VP, Chief Accounting Officer
Transactions
- Sale
Class A common stock
2023-09-05$169.20/sh−406$68,695→ 24,089 total
Footnotes (1)
- [F1]The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.